In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue
Open Access
- 8 February 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-9
Abstract
Mitochondria host key metabolic processes vital for cellular energy provision and are central to cell fate decisions. They are subjected to unique genetic control by both nuclear DNA and their own multi-copy genome - mitochondrial DNA (mtDNA). Mutations in mtDNA often lead to clinically heterogeneous, maternally inherited diseases that display different organ-specific presentation at any stage of life. For a long time, genetic manipulation of mammalian mtDNA has posed a major challenge, impeding our ability to understand the basic mitochondrial biology and mechanisms underpinning mitochondrial disease. However, an important new tool for mtDNA mutagenesis has emerged recently, namely double-stranded DNA deaminase (DddA)-derived cytosine base editor (DdCBE). Here, we test this emerging tool for in vivo use, by delivering DdCBEs into mouse heart using adeno-associated virus (AAV) vectors and show that it can install desired mtDNA edits in adult and neonatal mice. This work provides proof-of-concept for use of DdCBEs to mutagenize mtDNA in vivo in post-mitotic tissues and provides crucial insights into potential translation to human somatic gene correction therapies to treat primary mitochondrial disease phenotypes.Keywords
Funding Information
- RCUK | MRC | Medical Research Foundation (MC_UU_00015/4, MC_UU_00015/4)
- RCUK | Medical Research Council (MC_UU_00015/4, MC_UU_00015/4, MC_UU_00015/4)
This publication has 43 references indexed in Scilit:
- Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENsNature Medicine, 2013
- Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex INature Medicine, 2013
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonucleaseGene Therapy, 2011
- Construction and testing of engineered zinc-finger proteins for sequence-specific modification of mtDNANature Protocols, 2010
- Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNANucleic Acids Research, 2008
- Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromesGene Therapy, 2008
- Gene Therapy for Mitochondrial Disease by Delivering Restriction Endonuclease SmaI into MitochondriaJournal of Biomedical Science, 2002
- Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonucleaseHuman Molecular Genetics, 2001